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The often-noted and persistent increased incidence of 
Escherichia coli O157:H7 infections in rural areas is not well 
understood. We used a cohort of E. coli O157:H7 cases re-
ported in Washington, USA, during 2005–2014, along with 
phylogenomic characterization of the infecting isolates, to 
identify geographic segregation of and temporal trends in 
specific phylogenetic lineages of E. coli O157:H7. Kernel 
estimation and generalized additive models demonstrated 
that pathogen lineages were spatially segregated during 
the period of analysis and identified a focus of segregation 
spanning multiple, predominantly rural, counties for each of 
the main clinical lineages, Ib, IIa, and IIb. These results sug-
gest the existence of local reservoirs from which humans 
are infected. We also noted a secular increase in the pro-
portion of lineage IIa and IIb isolates. Spatial segregation 
by phylogenetic lineage offers the potential to identify local 
reservoirs and intervene to prevent continued transmission.
Escherichia coli O157:H7 infections cause major pub-lic health challenges. Most E. coli O157:H7 infections 
occur sporadically, and the source of infection is often dif-
ficult to identify with certainty (1,2). Many reported infec-
tions are attributed to food vehicles (1), but studies have 
implicated other risk factors, and environmental trans-
mission may be particularly notable in rural areas (3–7). 
Overall, the frequency of infections with E. coli O157:H7 
has fallen in the United States, which is likely related to 
improved food safety (8), but it is not clear that rural inci-
dence has also fallen.
Residing in a rural area confers increased risk for E. 
coli O157:H7 infection (9,10). E. coli O157:H7 can persist 
in certain locales, posing ongoing risk to humans. Multiple 
studies demonstrate that specific strains persist within cattle 
farms and spread to neighboring farms (11–15). The reser-
voirs enabling this persistence may include water, soil, and 
wild birds (16–19). It is, therefore, possible that humans in-
cidentally acquire E. coli O157:H7 infections because they 
reside in a geographic region with a persistent reservoir. 
Using a generalizable population-based cohort, we sought 
to test the hypothesis that there are geographic foci of re-
lated E. coli O157:H7 infections, most likely of environ-
mental origin, taking into account the genomic relatedness 
of different isolates (20,21) and the geographic, temporal, 
and secular attributes of their corresponding infections.
Methods
Study Population and Pathogen Characterization
We conducted a population-based retrospective cohort 
study of all culture-confirmed E. coli O157:H7 cases re-
ported to the Washington State Department of Health 
(DOH; Shoreline, WA, USA) during 2005–2014. E. coli 
O157:H7 case reporting mandated by the Washington Ad-
ministrative Code occurs primarily through diagnostic lab-
oratories and healthcare providers. Local health jurisdic-
tions use a standardized DOH case report form to abstract 
medical records; interview case-patients to obtain demo-
graphic information (including residence address), poten-
tial exposures, and details of the course of illness; and de-
termine the most likely source of infection. For this study, 
case addresses were geocoded and census block groups 
determined. Case data were deidentified for analysis. This 
study was deemed exempt by the Washington State Insti-
tutional Review Board.
All E. coli O157:H7 isolates are sent to DOH for mi-
crobiologic confirmation and XbaI pulsed-field gel elec-
trophoresis (PFGE) typing. We obtained isolates from 
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DOH and determined their lineage according to the phy-
logenetic tree developed by Bono et al. (20) and expanded 
by Jung et al., who identified some lineages as clinical 
and others as bovine-biased (21). We used the Jung et al. 
48-plex single-nucleotide polymorphism (SNP) assay to 
type a subset of isolates (21). We assumed that all iso-
lates with a given PFGE pattern would be SNP typed to 
the same lineage. Thus, we typed >1 isolate from each 
PFGE pattern in the dataset and inferred the lineage of 
nontyped isolates. Concordance among isolates with 
identical PFGE profiles was confirmed (online Technical 
Appendix, https://wwwnc.cdc.gov/EID/article/24/1/17-
0851-Techapp1.pdf). We analyzed the clinically common 
lineages Ib, IIa, and IIb separately and analyzed the bo-
vine-biased and remaining sparsely represented lineages 
(21) as a clinically rare group.
Phylogenetic Lineage Spatial Segregation
Spatial segregation is the ecologic concept that one spe-
cies or species type is more likely to be surrounded by like 
than by nonlike individuals (22). We used Diggle’s kernel 
estimation method (23) and spatialkernel package (24) in R 
(25) to test spatial segregation of E. coli O157:H7 by phy-
logenetic lineage (online Technical Appendix). In brief, 
we first estimated a smoothed probability surface for each 
lineage by comparing the distance between cases infected 
with the same lineage to the distance between cases infect-
ed with different lineages. A peak in the lineage-specific 
probability surface indicates an area with a high probability 
of that lineage, relative to the distribution of the other lin-
eages. For example, if 80% of cases in a given proximity 
are infected with lineage Ib but in all other areas lineage Ib 
causes only 50% of cases, we would observe a peak in the 
lineage Ib-specific probability surface, suggesting spatial 
segregation. To determine overall spatial segregation, the 
probability surfaces were compared with a null distribution 
in which the proportion of infections caused by each lin-
eage is constant across space. 
We next sought to account for potential confounders 
and to detect geographic trends. To do so, we modeled the 
risk surface using a multinomial generalized additive mod-
el (GAM). We estimated the effect of a bivariate thin plate 
regression spline smooth of latitude and longitude on the 
odds of infection with a given lineage compared with the 
most common lineage. This smoothing technique produces 
a risk surface that can vary flexibly across both horizontal 
and vertical coordinates. In this analysis, we compared lin-
eages IIa and IIb and the group of clinically rare lineages 
separately with lineage Ib, which served as the reference 
(most common) lineage. The model was adjusted for sex 
and age group (<5, 5–9, 10–19, 20–59, and >60 years); 
isolates from cases of unknown age (n = 1) or sex (n = 
10) were excluded from analysis. We estimated parameters 
using restricted maximum likelihood and the mgcv pack-
age in R (26,27). We further conducted a series of sensitiv-
ity analyses to determine the robustness of our results by 
seeking to confirm our results with 2 independent methods: 
Dixon’s nearest-neighbor test (22) and multinomial spatial 
scan statistics (28) (online Technical Appendix).
Temporal Variation in Spatial Segregation
To determine whether spatial segregation of lineages varied 
over time, we replicated our spatial segregation analyses 
incorporating time. To do so, we split the years of analysis 
into 3 intervals (2005–2007, 2008–2010, and 2011–2014) 
and calculated a kernel-based estimate of spatial segrega-
tion for each. We evaluated the effect of time in the multi-
nomial GAM by adding year to the model as a continuous 
variable, testing the effect of year as both a linear term and 
as a smoothed term using a thin plate spline. The thin plate 
spline allows the association between lineage and year to 
smoothly change in magnitude and direction.
Exploratory Risk Factor Analysis
We explored potential drivers of segregation by testing the 
association of risk factors included on the DOH case report 
form with each lineage compared with the reference lin-
eage Ib. Using multinomial GAMs adjusting for sex, age, 
year, and latitude and longitude as a thin plate spline bivari-
ate smoother, we tested each risk factor (online Technical 
Appendix Table 1). In addition to the statewide analyses, 
region-specific analyses were conducted for the 3 regions 
with the highest E. coli O157:H7 incidence to determine 
locally key associations. Regions were defined based on 
major population centers, areas of increased agricultural 
intensity, and observed segregation clusters, and models 
were adjusted for sex, age, and year.
Results
During the study period, 1,160 E. coli O157:H7 cases 
were reported to DOH. Of these, 33 isolates, represent-
ing 31 PFGE types, were not available for typing (online 
Technical Appendix), and isolates from 6 cases were ex-
cluded as biochemically atypical E. coli O157:H7 (online 
Technical Appendix Figure 1). We SNP typed 793 iso-
lates and, by extension, matched another 328 to a known 
lineage using PFGE, enabling us to assign a specific lin-
eage of E. coli O157:H7 to isolates from 1,121 cases. Ten 
cases lacked address data and were excluded, leaving 
1,111 cases for analysis.
Lineages Ib, IIa, and IIb, in descending order, were the 
most common lineages (Table). Twelve clinically rare lin-
eages were identified, including 2 not previously described, 
encompassing 45 unique PFGE types (online Technical 
Appendix Figure 1). Lineage Ib comprised 210 PFGE 
types, whereas lineage IIa comprised only 38 PFGE types 
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and lineage IIb 26 PFGE types (online Technical Appendix 
Figure 1). Lineage IIa contained an average of 7 (SD 14) 
and IIb an average of 8 (SD 25) isolates per PFGE type, 
compared with 3 (SD 5) for lineage Ib and 1 (SD 2) for the 
clinically rare lineages (Table).
Distribution of cases by sex, age group, and hemo-
lytic uremic syndrome (HUS) status varied by lineage 
(Table). Lineage IIa and IIb isolates originated dispro-
portionately from children <5 years of age compared 
with isolates in lineage Ib. Patients infected with lineage 
IIb bacteria also had higher frequencies of HUS (10%) 
than other patients (6%). None of the patients with infec-
tions caused by isolates from the clinically rare lineages 
developed HUS.
Spatial Segregation
The result of Diggle’s kernel estimation test was statisti-
cally significant (p = 0.001), suggesting spatial segrega-
tion. Lineage-specific probability surfaces showed sepa-
rate, distinct peaks for lineages Ib, IIa, and IIb (Figure 1). 
The southwest region of Washington was marked by seg-
regation of lineage IIb isolates and correspondingly lower 
probability of isolating lineage Ib from cases. Spatial seg-
regation was observed for lineage Ib isolates in northwest 
Washington and for lineage IIa isolates in the south-central 
region. There was low probability of lineage IIb isolates 
in both these areas. Sensitivity analysis corroborated these 
results (online Technical Appendix).
Consistent with the kernel regression results, the ad-
justed GAM risk surface of lineage IIb varied significantly 
from that of Ib (p<0.001), providing additional support of 
the spatial segregation. The frequency of lineage IIb iso-
lation was greater than the frequency of Ib in the south-
west region, but this imbalance diminished as latitude and 
longitude increased (Figure 2), that is, in areas northward 
and eastward. This spatial pattern was also observed in the 
kernel estimation map of lineage IIb (Figure 1). The risk 
surfaces of lineage IIa and the clinically rare lineage group 
did not differ significantly from that of Ib (online Techni-
cal Appendix Table 2). In sensitivity analyses designed to 
gauge the robustness of results to model assumptions, the 
spatial risk surface of lineage IIb consistently varied sig-
nificantly from the risk surface of lineage Ib (online Tech-
nical Appendix Table 2). The spatial risk surface of lineage 
IIa also varied significantly from the risk surface of lin-
eage Ib in some sensitivity analyses, similar to the spatial 
distribution in the kernel estimation lineage IIa–specific 
probability surface.
We also found significant differences in lineage by age 
of infected patients, independent of geography. The likeli-
hood of being an adult (age ranges 20–59 and >60 years 
of age) versus being a toddler (<5 years of age) was lower 
among IIa-infected patients than among Ib-infected patients 
(20–59 years odds ratio [OR] 0.65, 95% CI 0.44–0.96; >60 
years OR 0.49, 95% CI 0.28–0.85). The odds of being 20–
59 years of age versus <5 years were also lower among 
IIb-infected patients than among Ib-infected patients (OR 
0.44, 95% CI 0.28–0.69). Thus, adults comprised a smaller 
proportion of patients infected with lineage IIa or IIb E. 
coli O157:H7 than of those infected with lineage Ib. We 
found no significant differences by sex.
Temporal Variation
The incidence of E. coli O157:H7 averaged 1.73/100,000 
population during the study period. Although incidence 
fluctuated from a low of 1.37/100,000 population in 2014 
to a maximum of 2.28/100,000 population in 2013, we 
found no discernible trend in overall incidence. However, 
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Table. Escherichia coli O157:H7 lineage frequency by case characteristic among culture-confirmed human cases reported in 
Washington, USA, 2005–2014* 
Variable Lineage Ib Lineage IIa Lineage IIb Rare lineages† 
Total 586 (52.7) 260 (23.4) 199 (17.9) 66 (5.9) 
Mean isolates per PFGE type (SD)‡ 2.8 (5.3) 6.8 (14.3) 7.7 (24.7) 1.5 (1.7) 
Sex     
 F 333 (56.8) 163 (62.7) 105 (52.8) 33 (50.0) 
 M 244 (41.6) 97 (37.3) 94 (47.2) 32 (48.5) 
 Unknown 9 (1.5) 0 0 1 (1.5) 
Age group, y     
 <5 119 (20.3) 72 (27.7) 63 (31.7) 10 (15.2) 
 5–9 81 (13.8) 32 (12.3) 33 (16.6) 12 (18.2) 
 10–19 97 (16.6) 51 (19.6) 31 (15.6) 6 (9.1) 
 20–59 207 (35.3) 81 (31.2) 49 (24.6) 29 (43.9) 
 ≥60 81 (13.8) 24 (9.2) 23 (11.6) 9 (13.6) 
 Unknown 1 (0.2) 0 0 0 
HUS     
 Yes 37 (6.3) 18 (6.9) 20 (10.0) 0 
 No 526 (89.2) 236 (90.1) 173 (86.1) 67 (98.5) 
 Unknown 27 (4.6) 8 (3.1) 8 (4.0) 1 (1.5) 
*Values are no. (%) except as indicated. HUS, hemolytic uremic syndrome; PFGE, pulsed-field gel electrophoresis. 
†Twelve clinically rare lineages. 
‡PFGE type percentages indicate the proportion of PFGE types with an assigned lineage (n = 355) belonging to each lineage. 
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the composition of the E. coli O157:H7 population shifted 
over time (Figure 3). In the GAM analysis including year 
as a linear term, incidence relative to lineage Ib increased 
over time for lineage IIa (OR 1.26, 95% CI 1.19–1.34), lin-
eage IIb (OR 1.10, 95% CI 1.03–1.17), and clinically rare 
lineages (OR 1.13, 95% CI 1.02–1.26).
We observed a peak of lineage IIb incidence during 
the middle of the study period in southwest Washington 
and the Seattle–Tacoma region (Figure 3). Using kernel 
regression, we identified statistically significant temporal 
variation in spatial segregation across intervals (p = 0.001). 
We observed statistically significant overall spatial seg-
regation only during the 2008–2010 interval (p = 0.001). 
Some portion of the southwest region of the state showed 
increased probability of lineage IIb isolation during all 
intervals, and lineages Ib and IIa were segregated during 
2008–2010 and 2011–2014 (Video, https://wwwnc.cdc.
gov/EID/article/24/1/17-0851-V1.htm). Cross-validated 
log-likelihood bandwidths used in these analyses ranged 
from 0.73 to 1.0. In sensitivity analysis, a lower bandwidth 
yielded statistically significant spatial segregation during 
all periods (online Technical Appendix). Latitude and lon-
gitude remained significant predictors of Ib in GAMs that 
included year (online Technical Appendix Table 2).
Sensitivity Analysis
Alternate analytic approaches confirmed the results of our 
primary analyses. Dixon’s test for spatial segregation iden-
tified statistically significant spatial segregation overall, as 
well as for lineages Ib, IIa, and IIb (online Technical Ap-
pendix Tables 3, 4). Three clusters identified using multi-
nomial spatial scan statistics paralleled areas of segregation 
found in the kernel regression analysis and were consistent 
with the southwest trend toward proportionally greater IIb 
observed in the multinomial GAM (online Technical Ap-
pendix Figures 3, 4).
To focus on potential local reservoirs, which are 
not likely to be human, we also conducted the analysis 
without cases due to presumptive person-to-person trans-
mission (online Technical Appendix). We used the most 
likely source of infection documented on the DOH case 
report form to exclude patients most likely infected by 
other persons. After discounting secondary transmission, 
we observed spatial segregation using the kernel estima-
tion method (p = 0.002). The risk surface of lineage IIb 
still varied significantly from that of Ib (p<0.001). The 
trend toward greater IIb relative to Ib risk in southwest 
Washington was consistent with the analysis of all cases, 
but relative IIb risk was substantially lower in the north-
east region than that observed in the primary analysis. 
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Figure 1. Escherichia coli O157:H7 lineage frequency among culture-confirmed human cases reported in Washington, USA, 2005–2014. 
A) Lineage Ib; B) lineage IIa; C) lineage IIb; D) rare lineages (12 different clinically rare lineages). Lineage-specific probability surfaces were 
determined by kernel-based estimation of spatial segregation. Darker shading indicates higher risk for that lineage. Contour lines marked 
0.025 define areas in which there is a high probability of cases being caused by a given lineage, suggesting spatial segregation. Contour lines 
marked 0.975 define areas in which there is a low probability of cases being caused by the given lineage.
RESEARCH
This pattern suggests that lineage IIb infections in north-
east, but not southwest, Washington may be dispropor-
tionately attributed to secondary transmission compared 
with Ib infections. Finally, we found no evidence of case 
ascertainment bias that could independently explain our 
results (online Technical Appendix).
Exploratory Risk Factor Analysis
Statewide, patients infected with lineage IIa E. coli 
O157:H7 were more likely to have reported raw fruit or 
vegetable consumption than those infected with lineage Ib 
pathogens (OR 1.81, 95% CI 1.05–3.11). Patients infected 
with lineage IIb E. coli O157:H7 were more likely to have 
reported raw milk consumption than those infected with 
lineage Ib pathogens (OR 2.46, 95% CI 1.15–5.28). All 
examined risk factors and associations are summarized in 
online Technical Appendix Table 1.
Discussion
The geographic differences and temporal trends in the rela-
tive frequencies of lineages of E. coli O157:H7 from cases 
in Washington demonstrate that, in addition to genomic 
variation reported at the national level (29,30), persistent 
geogenomic variation exists at the regional level. Several 
geospatial associations warrant elaboration. In all analyses, 
lineage IIb cases were segregated in the southwest region 
of the state. Southwest Washington includes Olympia, the 
state capital, as well as suburbs of Portland, Oregon, north 
of the Columbia River; however 27% of the population in 
the 12 southwest region counties is considered rural, com-
pared with 16% of the state as a whole (31). Small farms 
are common. The southwest region is home to >20% of the 
state’s farms but accounts for only 7.1% of its cattle and 
6.3% of farm acreage (32). Roosevelt elk roam the south-
west region, and elk elsewhere in the country have been 
identified as Shiga toxin–producing E. coli carriers (33). 
Water is also a potential factor in E. coli O157:H7 epidemi-
ology in the southwest region, which has abundant coastal 
and river exposures. The largest recognized IIb outbreak in 
this region accounted for only 11 cases linked to a particu-
lar daycare center (out of 77 IIb infections in the region), 
so the observed segregation is unlikely due to a single point 
source. Notably, lineages IIa and IIb have the greatest over-
lap with the putatively hypervirulent clade 8 (34), making 
their segregation of particular concern.
Lineage IIb isolates were relatively uncommon in the 
northwest and south-central regions of Washington, both 
major cattle-production regions. Lineage Ib showed segre-
gation in the northwest and IIa in the south-central region 
in some analyses, although their adjusted risk surfaces did 
not differ significantly, suggesting overlap. More research 
is needed to clarify why lineage IIb has not yet also estab-
lished itself in areas with abundant cattle.
The presence of spatially segregated lineages indi-
cates local environmental reservoirs producing infections 
above and beyond those caused by widely distributed ex-
ogenous sources such as food. We propose that persistent 
spatial segregation of a lineage could reflect a founder 
effect, in which an ancestral pathogen has become estab-
lished in a region, persisted, and expanded and occasion-
ally crosses into the human population. Such a dynamic 
would result in phylogenetically similar bacteria being 
isolated in the same general geographic region separated 
by months or years, as we have observed in this study. 
A possible precedent exists in a report of 2 cases from 
Webster County, Missouri, USA (35). Our findings are 
also consistent with those of Jaros et al., who found that 
geography explains some variation in E. coli O157:H7 
strains in New Zealand (36). In addition, prior work from 
Washington demonstrated shifts over time in the Shiga 
toxin genotypes of E. coli O157:H7 (37).
The clinical infections in our study were dominated 
by E. coli O157:H7 in lineages Ib, IIa, and IIb, consistent 
with the results of Jung et al. (21). Our work is also con-
sistent with a national study showing that lineage Ib E. coli 
O157:H7 causes most clinical cases in the United States 
(30). Relative to lineage Ib, Washington experienced sta-
tistically significant increases in the other clinically com-
mon lineages during the study period. The increase is most 
dramatic for lineage IIa, which appears to have emerged in 
most regions in the latter half of the study period (Figure 3). 
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Figure 2. Risk surface of Escherichia coli O157:H7 lineage IIb 
relative to lineage Ib using a multinomial generalized additive 
model and a bivariate thin plate smooth function for longitude and 
latitude for culture-confirmed human cases reported in Washington, 
USA, 2005–2014. The black contour lines show the mean effect 
estimate for lineage IIb relative to Ib as latitude and longitude 
change. The 0-marked black line indicates no effect. The 1-marked 
black line indicates greater proportional incidence of lineage IIb 
toward the southwest corner of the area as compared to lineage 
Ib (p<0.001). The arrow indicates the general direction of the trend 
from higher Ib risk to higher IIb risk. Dashed red lines show the 
effect estimate 1 standard error (SE) below (to the south and west) 
the mean estimate. Dotted green lines show the effect estimate 1 
standard error above (to the north and east) the mean estimate. 
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This difference could reflect the changing epidemiology of 
E. coli O157:H7 discussed by Rivas et al., owing to chang-
es in food sources and consumption, or, possibly, pathogen 
evolution (38). Lineage IIa E. coli O157:H7 has emerged 
as a major cause of disease across the state, suggesting a 
disseminated driver of infections for this lineage overall. 
Lineage IIa’s observed association with raw fruit and veg-
etable consumption, as compared with that for lineage Ib, 
is consistent with this hypothesis. The south-central region 
of Washington, identified in some analyses as an area of 
IIa segregation, experienced an uptick in IIa infections ear-
lier than in other regions. This area includes the Yakima 
Valley, an area of higher agricultural intensity; a local IIa 
reservoir in this region could produce the observed segre-
gation independent of statewide trends.
Our findings suggest exposures that may be prefer-
entially associated with particular lineages. Specifically, 
we observed associations of lineage IIb with drinking 
untreated/unchlorinated water and raw milk in the south-
west region, where this lineage is segregated (online Tech-
nical Appendix Table 1). There may be a lineage IIb reser-
voir in animals producing raw milk in this area, or bacteria 
from environmental reservoirs in the area may spill over 
into these animals and local water sources. Only 1 small, 
recognized raw milk outbreak in 2005 was noted on the 
DOH case report forms, making it unlikely that a single 
source is responsible for the association we found over 
time. It is possible that some E. coli O157:H7 lineages may 
be especially successful in surviving in particular vehicles 
or environments, such as raw produce or unpasteurized 
milk or water. Secular changes might also be the result of 
shifting environmental exposure risk if, for example, con-
tact between a reservoir and humans varies over time. Bet-
ter knowledge of small-intermediate area transmission pat-
terns will open opportunities for intervention if reservoirs 
can be identified.
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Figure 3. Annual incidence (per 
100,000 population) of reported 
Escherichia coli O157:H7 
cases by phylogenetic lineage, 
Washington, USA, 2005–2014. 
A) Statewide; B) northwest 
region; C) Seattle–Tacoma 
region; D) southwest region; 
E) northeast region; F) south-
central region. Regions were 
defined according to major 
demographic characteristics 
and patterns of segregation 
observed in analyses for the 
whole period. The northwest 
region experienced the highest 
peak incidence. The Seattle–
Tacoma region and the northeast 
region experienced the lowest 
incidences. “Rare” indicates 12 
different clinically rare lineages.
Video. Lineage-specific 
probability surfaces for 
Escherichia coli O157:H7 
from culture-confirmed 
human cases reported in 
Washington, USA, 2005–2014. 
Probabilities were determined 
by kernel-based estimation 
of spatial segregation for 3 
intervals: 2005–2007 (n = 305, 
bandwidth = 1.0000); 2008–2010 
(n = 367, bandwidth = 0.7256); 
and 2011–2014 (n = 439, 
bandwidth = 0.9314). Overall 
spatial segregation was not statistically significant for the 2005–2007 interval (p = 0.769) or 2011–2014 interval (p = 0.138) but was 
statistically significant for the 2008–2010 interval (p = 0.001). Circles indicate case locations. Darker hues indicate higher risk. Contour 
lines marked 0.025 define areas in which there is a high probability of cases being caused by a given lineage, suggesting spatial 
segregation. There is an area of statistically significant spatial segregation for lineage IIb in all 3 intervals. Contour lines marked 0.975 
define areas in which there is a low probability of cases being caused by the given lineage.
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Our study is limited by its reliance on SNP data to 
define phylogenetic lineages. Whole-genome sequenc-
ing would have supported finer resolution of relatedness, 
particularly among isolates that were segregated in time 
and space, and enabled us to trace the history of segregat-
ed clusters. Such an analysis would not necessarily alter 
our conclusions, however, because evolution of specific 
clades of E. coli O157:H7 within a region, and the identi-
fication of different sublineages, would still be consistent 
with a founder effect. In fact, the precise delineation of the 
chromosomal architecture in these pathogens might actu-
ally confirm a common progenitor, as demonstrated from 
worldwide analyses of E. coli O157:H7 (39). Our use of 
phylogenetic lineages rather than PFGE profiles is also a 
strength of the work, because PFGE does not put differ-
ences into evolutionary perspective (39). By basing the 
analysis on phylogenetic lineages, we captured relatedness 
among strains and indicate the level of E. coli O157:H7 di-
versity as it circulates through its host populations. We also 
used multiple analytic techniques to provide confidence 
that our results were not due to assumptions made by any 
particular method.
In summary, clusters of spatial segregation by phy-
logenetic lineage in Washington suggest local reservoirs 
that perennially cause human disease. Further exploration 
of land use, human movements, and social–behavioral 
factors could elucidate within-region drivers of spatial 
segregation. We see comparison of lineage-specific spa-
tial patterns with distributions of these and other factors 
as an essential next step in understanding E. coli O157:H7 
spatial segregation. Environmental risk assessment and 
longitudinal studies based on our findings would also 
provide valuable information by identifying pathogen 
reservoirs that have not been identified by traditional 
public health surveillance and that could be mitigated by 
public health or environmental measures. The makeup of 
the E. coli O157:H7 population in the state is also shift-
ing. To manage emerging lineages, attention is needed 
to the heterogeneity in risk factors across the phyloge-
netic tree. Greater knowledge of the most likely sources 
of infection for particular lineages has the potential to 
focus both outbreak investigations and efforts to identify 
persistent reservoirs.
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